Repligen Corporation (RGEN)

Last Price:  

Company Description

Repligen Corporation is a life sciences company focused on the development, production and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Their bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. They are a leading manufacturer of Protein A, a critical reagent used to separate and purify monoclonal antibody therapeutics. They also supply several growth factor products used to increase cell culture productivity during the fermentation stage of drug manufacturing. In addition, they have developed and marketed their OPUS? series of pre-packed `plug-and-play` chromatography columns, and they provide test kits to ensure final product quality. Aside from their core bioprocessing business, they have a portfolio of clinical-stage partnering assets, including a pancreatic imaging agent in Phase 3 development and an orphan drug candidate in Phase 1 development.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $366.26M
Net Income (Most Recent Fiscal Year) $59.93M
PE Ratio (Current Year Earnings Estimate) 104.46
PE Ratio (Trailing 12 Months) 120.40
PEG Ratio (Long Term Growth Estimate) 2.75
Price to Sales Ratio (Trailing 12 Months) 29.89
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 6.88
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 82.73
Pre-Tax Margin (Trailing 12 Months) 16.17%
Net Margin (Trailing 12 Months) 16.36%
Return on Equity (Trailing 12 Months) 7.42%
Return on Assets (Trailing 12 Months) 5.74%
Current Ratio (Most Recent Fiscal Quarter) 2.83
Quick Ratio (Most Recent Fiscal Quarter) 2.53
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) 2.05
Book Value per Share (Most Recent Fiscal Quarter) $29.06
Earnings per Share (Most Recent Fiscal Quarter) $0.52
Earnings per Share (Most Recent Fiscal Year) $1.65
Diluted Earnings per Share (Trailing 12 Months) $1.11
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Common Shares Outstanding 54.77M
Free Float 53.84M
Market Capitalization $10.95B
Average Volume (Last 20 Days) 0.32M
Beta (Past 60 Months) 0.85
Percentage Held By Insiders (Latest Annual Proxy Report) 1.70%
Percentage Held By Institutions (Latest 13F Reports) 86.13%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%